Skip to main content

Day: July 21, 2025

Foresight Reports Second Quarter 2025 Results

WINNEBAGO, Ill., July 21, 2025 (GLOBE NEWSWIRE) — Foresight Financial Group, Inc. (OTCQX: FGFH) reported net income of $2.99 million for the quarter ended June 30, 2025, an 8% decrease compared to the $3.27 million reported for the second quarter of 2024, and a 307% increase compared to the $734 thousand reported for the first quarter of 2025. Diluted Earnings per Share for the second quarter was $0.82 compared to $0.94 for the second quarter of 2024 and $0.20 for the quarter ended March 31, 2025. The second quarter of 2025 results include $1.56 million of charter consolidation expenses, which were partially offset by nonrecurring revenue of $1.20 million related to a debit card branding agreement. The second quarter results produced a Return on Average Equity of 7.60% and Return on Average Assets of 0.75%. Net income for the six...

Continue reading

OceanPal Inc. Announces Pricing of Upsized US$18.0 Million Public Offering

ATHENS, Greece, July 21, 2025 (GLOBE NEWSWIRE) — OceanPal Inc. (NASDAQ: OP) (the “Company”), a global shipping company specializing in the ownership of vessels, today announced the pricing of its upsized public offering of 10,975,600 units at a public offering price of US$1.64 per unit. Each unit consists of one common share and one warrant to purchase one common share. Each Warrant will expire three (3) years from the issuance, will be immediately exercisable upon issuance at an initial exercise price equal to 225% of the public offering price, subject to adjustment on the First Reset Date and the Second Reset Date (as defined in the warrants) and subject to a floor price therein. The warrants may also be exercised on a zero cash exercise option pursuant to which the holder may exchange each warrant for two (2) common shares. Gross...

Continue reading

ONAR Appoints Former MDC Partners Chairman & CEO Scott Kauffman to Lead Board, Signaling Aggressive Growth Strategy

Miami, FL, July 21, 2025 (GLOBE NEWSWIRE) — ONAR Holding Corporation (OTCQB: ONAR), a fast-growing marketing technology company and global network of performance-driven agencies, today announced the appointment of Scott Kauffman, former Chairman and CEO of MDC Partners, as Chairman of its Board of Directors. This strategic move signals a new chapter of accelerated growth, M&A focus, and industry leadership for ONAR. Kauffman brings over three decades of executive and board experience spanning marketing, media, ecommerce, and digital innovation. As Chairman & CEO of MDC Partners, Kauffman led the company through a transformative period that culminated in its combination with Stagwell Marketing Group Holdings, forming Stagwell Inc. (NASDAQ: STGW)—a $3B+ global marketing powerhouse. “This landmark appointment represents...

Continue reading

Longeveron® Announces Licensing of New Cardiac Selective Induced Pluripotent Stem Cell Technology for Cardiovascular Disease

Joshua HareJoshua Hare, MD, FACC, FAHA, Co-Founder, Chief Science Officer and Chairman, LongeveronLongeveron has licensed issued US Patent 12,168,028 B2, entitled “Methods for obtaining cardiomyogenic precursor cells” from the University of Miami New patent protects a method to derive GHRH-Receptor+ cardiomyogenic cells from pluripotent stem cells (PSCs) New technology substantially advances Longeveron’s repertoire of stem cell therapy technologies Opportunity to expand pipeline in cardiovascular, rare and pediatric disease areasMIAMI, July 21, 2025 (GLOBE NEWSWIRE) —  Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, rare pediatric, and chronic aging-related conditions, today announced that it has licensed an issued US patent...

Continue reading

NextNRG Announces Completion of Strategic Financial Restructuring Reducing Monthly Burn by Approximately $1 Million

Company Converts Debt to Restricted Common Stock at Premium to Market and Refinances High-Cost Debt with 8-Month Note MIAMI, July 21, 2025 (GLOBE NEWSWIRE) — NextNRG, Inc. (Nasdaq: NXXT), a pioneer in AI-driven energy innovation transforming how energy is produced, managed, and delivered through its Next Utility Operating System®, smart microgrids, wireless EV charging, and mobile fuel delivery, today announced the completion of a comprehensive financial restructuring that significantly reduces the company’s monthly cash burn by approximately $1 million. The restructuring consists of two key transactions: a debt conversion agreement that converts existing debt obligations to equity at a premium to market, and a strategic refinancing that replaces high-cost short-term debt with an 8-month $2 million note. Under the debt conversion...

Continue reading

Woodward Completes Acquisition of Safran’s North American Electromechanical Actuation Business

Industry-leading electromechanical actuation portfolio adds to Woodward’s shipset content for widebody programs and expands strategic position for next generation aircraft FORT COLLINS, Colo., July 21, 2025 (GLOBE NEWSWIRE) — Woodward (NASDAQ: WWD), a global leader in aerospace and industrial energy control solutions, announced today it has completed its acquisition of Safran’s Electronics & Defense electromechanical actuation business based in the United States, Mexico, and Canada. The acquisition, first announced in December 2024, includes intellectual property, operations assets, talent, and long-term customer agreements, including those for Horizontal Stabilizer Trim Actuation (HSTA) systems for aircraft stabilization to support safe and efficient flight, notably used for the Airbus A350.  The A350 HSTA, a key product...

Continue reading

Senti Bio’s Chief Medical Officer, Kanya Rajangam, M.D., Ph.D. to Give Feature Presentation at the BioScience Forum

Presentation to highlight how Senti Bio’s novel first-in-class logic-gated CAR-NK cell therapy kills leukemic cells while protecting healthy bone marrow SOUTH SAN FRANCISCO, Calif., July 21, 2025 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that it will present at the BioScience Forum being held July 23, 2025 in San Carlos, CA. Details of the presentation are as follows: Title: Using Logic Gated CARs to Drive Cancer TreatmentSpeaker: Kanya Rajangam, M.D., Ph.D., President, Head of Research & Development and Chief Medical Officer of Senti BioDate and Time: Wednesday, July 23rd at 6:00 PM PT The BioScience Forum is a non-profit...

Continue reading

Sagtec Global Limited Achieves 144% Growth in Revenue and 308% Profit Surge for 1H2025

KUALA LUMPUR, Malaysia, July 21, 2025 (GLOBE NEWSWIRE) — Sagtec Global Limited (NASDAQ: SAGT) (“Sagtec” or the “Company”), a leading provider of customizable software solutions, today announced its audited financial results for the six month ended June 30, 2025 (the “Interim Results”) (the “Financial Results”).Revenue surged 144% year-over-year (YoY) to US$11.4 million for six-month period ended June 30, 2025, driven by strong growth across both services and tangible products. Net profit rose 308% YoY to US$1.9 million, reflecting higher operating income, improved gross margins, and increased other income. Gross profit increased 173% to US$2.3 million, supported by robust demand and operating leverage. Cash position strengthened significantly to US$454 thousand, compared to US$87.9 thousand at the beginning of the period.“Our...

Continue reading

Colabor Announces the Date of Its Second Quarter 2025 Results Conference Call

SAINT-BRUNO-DE-MONTARVILLE, Quebec, July 21, 2025 (GLOBE NEWSWIRE) — Colabor Group Inc. (TSX: GCL) (“Colabor” or the “Company”) will release its results for the first quarter ended June 14, 2025, after market close on Thursday, July 24, 2025. A conference call to discuss these results will be held on Friday, July 25, 2025 at 9:30 a.m. (Eastern Time). Conference Call: A live broadcast of the conference call will be available on the Company’s website, in the Investors section under Events and presentations. To participate (professional investment community only) or to listen to the live conference call:Date: Friday, July 25, 2025Time: 9:30 a.m. (Eastern Time)   Conference Number: 34320North-American participants dial toll-free: 1-800-990-4777International and local dial-in: 1-289-819-1299 or 1-514-400-3794You...

Continue reading

TSA PreCheck® Enrollment Available at the ItsEasy.com Offices in the Iconic NYC Locations: The MetLife Building and Rockefeller Center

ItsEasy.com and Telos Corporation announce new TSA PreCheck enrollment centers, reinforcing their commitment to making travel as easy and convenient as possible NEW YORK and ASHBURN, Va., July 21, 2025 (GLOBE NEWSWIRE) — ItsEasy.com Passport & Visa Services, the leading passport and visa expediting company that has processed over 2 million passport and visa applications, and Telos Corporation (NASDAQ: TLS), an authorized TSA PreCheck® enrollment provider, today announced the unveiling of two permanent TSA PreCheck enrollment centers at ItsEasy.com’s NYC office locations within the iconic and easily accessible Manhattan landmarks, the MetLife Building and Rockefeller Center (Concourse Level). This announcement follows the successful pop-up enrollment events held in March 2025 at these locations. “Partnering with Telos to offer...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.